Imatinib induces ferroptosis in gastrointestinal stromal tumors by promoting STUB1-mediated GPX4 ubiquitination

主旨 GPX4 癌症研究 泛素连接酶 泛素 伊马替尼 间质细胞 生物 化学 谷胱甘肽 生物化学 基因 酶 髓系白血病 谷胱甘肽过氧化物酶
作者
Xiangfei Sun,Qiang Zhang,Xiaohan Lin,Ping Shu,Xiaodong Gao,Kuntang Shen
出处
期刊:Cell Death and Disease [Springer Nature]
卷期号:14 (12): 839-839 被引量:60
标识
DOI:10.1038/s41419-023-06300-2
摘要

Abstract Imatinib (IM) has significantly improved the prognosis of gastrointestinal stromal tumor (GIST) patients, but some patients still have primary resistance to IM, and approximately half of patients develop acquired drug resistance within 2 years of treatment, necessitating exploration of new treatment strategies. Targeting ferroptosis as a novel approach to tumor treatment has gained attention. Yet, there is limited research on ferroptosis in GIST, and the underlying mechanism remains unclear. In this study, we revealed that IM increased lipid reactive oxygen species and intracellular Fe 2+ levels, and decreased glutathione levels in GIST. This effect could be partially inhibited by Ferrostatin-1. Additionally, knocking down STUB1 and overexpressing GPX4 reversed the IM-induced ferroptosis effect. Moreover, STUB1 was identified as a novel E3 ubiquitin ligase of GPX4, promoting the ubiquitination at site K191 of GPX4. The combination of the GPX4 inhibitor RSL3 and IM synergistically induces ferroptosis, inhibiting GIST proliferation both in vivo and in vitro. Furthermore, STUB1 and GPX4 expression serve as independent prognostic factors for GIST. In conclusion, This study is the first to demonstrate that IM induces ferroptosis by promoting STUB1-mediated GPX4 ubiquitination in GIST, and the combination of RSL3 and IM emerges as a promising therapeutic strategy for GIST.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
清酒完成签到,获得积分10
1秒前
KX发布了新的文献求助10
1秒前
1秒前
辛勤电源发布了新的文献求助30
2秒前
CodeCraft的应助被开朗的慕儿采纳,获得10
2秒前
2秒前
乐乐的应助被孤独听雨的猫采纳,获得10
2秒前
3秒前
Happyocean发布了新的文献求助10
3秒前
沧海月明完成签到,获得积分10
5秒前
诸葛烤鸭发布了新的文献求助10
5秒前
6秒前
橙神完成签到,获得积分10
6秒前
6秒前
cdercder的应助被nissy采纳,获得10
6秒前
7秒前
8秒前
干就完完成签到,获得积分20
8秒前
8秒前
明天太好完成签到,获得积分10
8秒前
yi发布了新的文献求助10
8秒前
隐形曼青的应助被Present采纳,获得30
9秒前
hyper完成签到 ,获得积分10
9秒前
9秒前
123发布了新的文献求助10
9秒前
9秒前
大模型的应助被LLL采纳,获得10
9秒前
9秒前
10秒前
10秒前
碎觉觉发布了新的文献求助30
10秒前
10秒前
顺利毕业发布了新的文献求助10
10秒前
11秒前
Moonber发布了新的文献求助10
11秒前
Linus完成签到,获得积分10
12秒前
千空发布了新的文献求助10
13秒前
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148